| scholarly article | Q13442814 |
| P2093 | author name string | T Zhang | |
| S B Calderwood | |||
| S L Stanley | |||
| E T Ryan | |||
| M A Baker | |||
| J R Butterton | |||
| P2860 | cites work | M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration | Q45717806 |
| Expression of a recombinant Entamoeba histolytica antigen in a Salmonella typhimurium vaccine strain | Q50168662 | ||
| Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit | Q54191083 | ||
| Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. | Q54378370 | ||
| Development of a live, oral, attenuated vaccine against El Tor cholera | Q57924437 | ||
| Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge | Q57924808 | ||
| Duration of infection-derived immunity to cholera | Q70831304 | ||
| Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies | Q71616346 | ||
| Amebiasis | Q71716561 | ||
| Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice | Q72155700 | ||
| A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess | Q72592782 | ||
| Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains | Q72746081 | ||
| THE TOXIC EFFECT OF ENTAMOEBA HISTOLYTICA ON LEUCOCYTES | Q76966939 | ||
| Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
| Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development | Q28485732 | ||
| Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype | Q30420490 | ||
| Adherence of Entamoeba histolytica trophozoites to rat and human colonic mucosa. | Q30451145 | ||
| Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells | Q30451207 | ||
| Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats | Q33256212 | ||
| Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory | Q34225394 | ||
| Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines | Q34520511 | ||
| Chinese hamster ovary cells deficient in N-acetylglucosaminyltransferase I activity are resistant to Entamoeba histolytica-mediated cytotoxicity | Q35088208 | ||
| Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. | Q35383979 | ||
| Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. | Q35400277 | ||
| Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates | Q35413377 | ||
| Heterologous antigen expression in Vibrio cholerae vector strains | Q35423953 | ||
| Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess | Q35486883 | ||
| Development of a germfree mouse model of Vibrio cholerae infection. | Q35526942 | ||
| Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains | Q35548775 | ||
| Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. | Q35775983 | ||
| Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR. | Q35777337 | ||
| Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica | Q35783115 | ||
| Progress towards an amebiasis vaccine | Q35846125 | ||
| CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. | Q36262564 | ||
| Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae | Q37395794 | ||
| The liver and IgA: immunological, cell biological and clinical implications | Q38619047 | ||
| Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. | Q39824053 | ||
| Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. | Q40762647 | ||
| Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit | Q41877655 | ||
| The serine-rich Entamoeba histolytica protein is a phosphorylated membrane protein containing O-linked terminal N-acetylglucosamine residues | Q42066846 | ||
| An optimized freeze-squeeze method for the recovery of DNA fragments from agarose gels | Q43806909 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| Entamoeba histolytica | Q131027 | ||
| Vibrio cholerae | Q160821 | ||
| immunization | Q1415366 | ||
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 3118-3125 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice | |
| P478 | volume | 65 |
| Q34484003 | A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mic |
| Q50126055 | A cloning vector for efficient generation of cholera toxin B gene fusions for epitope screening |
| Q52684483 | A self-assembling whole cell vaccine antigen presentation platform. |
| Q24598726 | Cholera toxin: a paradigm of a multifunctional protein |
| Q35098194 | Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera |
| Q36045133 | Construction and Evaluation of a Safe, Live, Oral Vibrio cholerae Vaccine Candidate, IEM108 |
| Q36480147 | Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit |
| Q34003042 | Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae |
| Q35896020 | Enteric pathogens as vaccine vectors for foreign antigen delivery |
| Q34403586 | Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide |
| Q37002887 | Exploiting cholera vaccines as a versatile antigen delivery platform |
| Q30407857 | Expression, purification, and evaluation of recombinant LecA as a candidate for an amebic colitis vaccine |
| Q77613864 | Host-pathogen interaction in amebiasis and progress in vaccine development |
| Q34003489 | In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae |
| Q34000827 | In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae |
| Q34003405 | Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains |
| Q30441436 | Participation of the serine-rich Entamoeba histolytica protein in amebic phagocytosis of apoptotic host cells |
| Q35375735 | Progress towards development of a vaccine for amebiasis. |
| Q55042601 | Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. |
| Q39676828 | Surface display of foreign epitopes on the Lactobacillus brevis S-layer |
| Q38185911 | The future for vaccine development against Entamoeba histolytica |
| Q36445329 | The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. |
| Q35867213 | Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice |
| Q37386803 | Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice |
Search more.